APA
SEEL

American Portfolios Advisors’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

American Portfolios Advisors’s Portfolio SEEL Stock Details SEEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Hold
0
– -$4.99K – 3460
2021
Q1 		– Sell
-1
Closed -$11.7K – 2698
2020
Q4 		$4.74K Hold
1
– – ﹤0.01% 2438
2020
Q3 		$2.81K Buy
+1
New +$3.59K ﹤0.01% 2487

Other funds holding SEEL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
GJL
Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

American Portfolios Advisors's SEEL Position: Q2 2021 in Review

American Portfolios Advisors held its Seelos Therapeutics, Inc. Common Stock (SEEL) position steady in Q2 2021 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #3460.

American Portfolios Advisors first reported a position in SEEL in Q3 2020 and has held it in 2 quarters since. The position peaked at $4.74K in Q4 2020. 92 funds tracked by Wall St. Rank hold SEEL as of Q2 2021.

  • American Portfolios Advisors held 0 shares of Seelos Therapeutics, Inc. Common Stock worth $0 as of Q2 2021.
  • American Portfolios Advisors left its Seelos Therapeutics, Inc. Common Stock share count unchanged in Q2 2021.
  • Seelos Therapeutics, Inc. Common Stock made up ﹤0.01% of American Portfolios Advisors's portfolio in Q2 2021, its #3460 holding.
  • American Portfolios Advisors first reported a position in Seelos Therapeutics, Inc. Common Stock in Q3 2020 and has held it in 2 quarters since.
  • American Portfolios Advisors's Seelos Therapeutics, Inc. Common Stock position peaked at $4.74K in Q4 2020.
  • 92 funds tracked by Wall St. Rank held Seelos Therapeutics, Inc. Common Stock as of Q2 2021.

Based on American Portfolios Advisors's 13F filing for Q2 2021, filed 22 Mar 2023.